Eventually, the patient relapsed which could be attributed to a small subset of MM cells which did not express BCMA on its surface and therefore were not selected by anti-BCMA CAR-T cell therapy (32). The gene discussed is TNFRSF17; the disease is Miyoshi myopathy.